Cortronix Biomedical Advancement Technologies Inc (OTC Pink - Limited Information:CBAT)

Data as of Jan 23
 0.00 / --
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

Cortronix Biomedical Advancement Technologies, Inc. is a biomedical company with a core competency in mobile cardio devices. The company is currently developing software that are designed to run on various mobile software platforms, including but not limited to the AndroidTM operating system. CorTronix BioMedical's proprietary software will be able to be used on any existing tablet and also creating its CorTabTM, which will have all necessary technology integrated into a single unit that will be available for sale or lease through the company directly. The company was founded on October 4, 2006 and is headquartered in Doral, FL.

Contact Information

Cortronix Biomedical Advancement Technologies, Inc.
8200 NW 41st Street
Doral Florida 33166
P:(786) 859-3585
Investor Relations:



Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Richard A. HullPresident, CEO, CFO, Secretary & Treasurer

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.